论文部分内容阅读
目的分析生化指标对恶性梗阻性黄疸患者临床症状的关系,为临床护理人员依据生化指标采取应对措施提供参考。方法对178例恶性梗阻性黄疸患者采用欧洲癌症研究与治疗组织系列核心量表(EORTC QLQ-C30)中的症状条目和恶性梗阻性黄疸患者特异性条目池(QLQ-MOJ11)于患者入院后进行临床症状测评。结果高胆红素、前白蛋白<170mg/L、CA19-9>200U/mL患者在疲倦、食欲丧失、气促、腹泻、黄疸、消化、瘙痒、消瘦、发热症状领域表现突出。结论胆红素、前白蛋白及CA19-9为影响恶性梗阻性黄疸患者临床症状的主要生化指标,临床护理人员应有针对性地为患者提供护理措施。
Objective To analyze the relationship between biochemical indexes and clinical symptoms in patients with malignant obstructive jaundice and provide reference for clinical nurses to take countermeasures based on biochemical indexes. Methods A total of 178 patients with malignant obstructive jaundice were enrolled after symptom onset in patients with malignant obstructive jaundice and patient-specific entry pool (QLQ-MOJ11) in the EORTC QLQ-C30 core scale Clinical symptoms evaluation. Results High bilirubin, prealbumin <170mg / L and CA19-9> 200U / mL patients showed outstanding performance in the fields of tiredness, loss of appetite, shortness of breath, diarrhea, jaundice, digestion, itching, weight loss and fever. Conclusions Bilirubin, prealbumin and CA19-9 are the main biochemical indicators of clinical symptoms in patients with malignant obstructive jaundice. Clinical nurses should provide targeted nursing measures for patients.